Article Details

Provectus Biopharmaceuticals Announces Stockholder Approval - GlobeNewswire

Retrieved on: 2022-06-23 13:42:01

Tags for this article:

Click the tags to see associated articles and topics

Provectus Biopharmaceuticals Announces Stockholder Approval - GlobeNewswire. View article details on HISWAI: https://www.globenewswire.com/news-release/2022/06/23/2468120/0/en/Provectus-Biopharmaceuticals-Announces-Stockholder-Approval-to-Undertake-Reverse-Split-of-Outstanding-Equities-and-Reduce-Number-of-Authorized-Equities-by-Same-Ratio.html

Excerpt

Provectus Biopharmaceuticals, Inc. (Provectus or the Company) is a clinical-stage biotechnology company developing immunotherapy medicines for ...

Article found on: www.globenewswire.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up